FIM
NRIX icon

Fernwood Investment Management’s Nurix Therapeutics NRIX Stock Holding History

Fernwood Investment Management’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,681
Closed -$218K – 184
2024
Q3 		$218K Hold
9,681
– – 0.07% 173
2024
Q2 		$202K Hold
9,681
– – 0.06% 191
2024
Q1 		$142K Buy
+9,681
New +$104K 0.04% 230

Other funds holding NRIX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fernwood Investment Management's NRIX Position: Q4 2024 in Review

Fernwood Investment Management sold out of Nurix Therapeutics (NRIX) in Q4 2024, closing a stake of 9,681 shares — an estimated $218K sold.

Fernwood Investment Management first reported a position in NRIX in Q1 2024 and held it in 3 quarters. The position peaked at $218K in Q3 2024. 175 funds tracked by Wall St. Rank hold NRIX as of Q4 2024.

  • Fernwood Investment Management reported no remaining Nurix Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Fernwood Investment Management sold 9,681 Nurix Therapeutics shares in Q4 2024, an estimated $218K.
  • Fernwood Investment Management first reported a position in Nurix Therapeutics in Q1 2024 and held it in 3 quarters.
  • Fernwood Investment Management's Nurix Therapeutics position peaked at $218K in Q3 2024.
  • 175 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q4 2024.

Based on Fernwood Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.